25.94 USD
↗ 0.44 (1.73%)AT CLOSE (11:59 AM EDT)
Yarrow Bioscience, Inc. Common Stock
YARWNASDAQ • USD
25.67
↘ 0.27 (1.04%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
25.67
↘ 0.27 (1.04%)
Market: CLOSED
Shares of Yarrow Bioscience, Inc. Common Stock (YARW) are trading at $26.24. The technical outlook is "Strong Sell" based on moving average alignment, RSI, and MACD signals. Key drivers include a bearish Death Cross on the long-term moving averages.
Technical & fundamental data as of Sep 16, 2026.
Open?$25.38
High?$26.95
Low?$24.00
Prev. Close?$25.50
Volume?74.2K
Avg. Volume?N/A
VWAP?$26.22
Bid / Ask
Bid?$22.53 × 100
Ask?$30.72 × 100
Spread?$8.19
Midpoint?$26.63
Valuation & Ratios
Market Cap?68.1M
Shares Out?2.7M
Float?31.6M
Float %?94.8%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Yarrow Bioscience Inc is a clinical-stage biopharmaceutical company focused on developing biotherapeutics for autoimmune thyroid diseases. Its flagship product candidate, YB-101 (also known as GenSci098), is a humanized, monoclonal antibody targeting the thyroid-stimulating hormone receptor, which Yarrow plans to develop for the treatment of Graves' disease (GD) and potentially thyroid eye disease (TED). The company has one reportable segment relating to the research and development of its research programs, GD and TED.
Employees
N/A
Market Cap
68.1M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2026-07-28
Address
470 JAMES STREET, SUITE 007
NEW HAVEN, CT 06513
Phone: (203) 433-7577
NEW HAVEN, CT 06513
Phone: (203) 433-7577
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestLow
Short % of Float?0.18%Low
Short Interest?56.5K
Days to Cover?1.2
Free Float31.6M
Avg Daily Volume46.9K
Settlement Date2026-08-31